In the last trading session, 1.7 million shares of the Evolent Health Inc (NYSE:EVH) were traded, and its beta was 1.48. Most recently the company’s share price was $9.94, and it changed around $0.09 or 0.91% from the last close, which brings the market valuation of the company to $1.16B. EVH currently trades at a discount to its 52-week high of $35.00, offering almost -252.11% off that amount. The share price’s 52-week low was $9.56, which indicates that the current value has risen by an impressive 3.82% since then. We note from Evolent Health Inc’s average daily trading volume that its 10-day average is 1.72 million shares, with the 3-month average coming to 2.81 million.
Evolent Health Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.13. If we narrow it down even further, the data shows that 0 out of 16 analysts rate the stock as a Sell; another 5 rate it as Overweight. Among the rest, 1 recommended EVH as a Hold, whereas 10 deemed it a Buy, and 0 rated it as Underweight.
Evolent Health Inc (NYSE:EVH) trade information
Instantly EVH has showed a green trend with a performance of 0.91% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 10.54 on recent trading dayincreased the stock’s daily price by 5.69%. The company’s shares are currently down -11.64% year-to-date, but still down -2.64% over the last five days. On the other hand, Evolent Health Inc (NYSE:EVH) is -21.11% down in the 30-day period. We can see from the shorts that 11.29 million shares have been sold at a short interest cover period of 5.2 day(s).
The consensus price target as assigned by Wall Street analysts is $19, which translates to bulls needing to increase their stock price by 47.68% from its current value. Analyst projections state that EVH is forecast to be at a low of $14 and a high of $38.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -13.43%. Evolent Health Inc earnings are expected to increase by -18.60% in 2025, but the outlook is positive 0.83% per year for the next five years.
EVH Dividends
Evolent Health Inc’s next quarterly earnings report is expected to be released in March.
Evolent Health Inc (NYSE:EVH)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 2.26% of Evolent Health Inc shares, and 114.31% of them are in the hands of institutional investors. The stock currently has a share float of 116.96%. Evolent Health Inc stock is held by 360.0 institutions, with WELLINGTON MANAGEMENT GROUP LLP being the largest institutional investor. By 2024-06-30, it held 9.785% of the shares, which is about 11.17 million shares worth $213.55 million.
VANGUARD GROUP INC, with 9.6862% or 11.06 million shares worth $211.39 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
Vanguard Specialized-Health Care Fund and Vanguard Total Stock Market Index Fund were the top two Mutual Funds as of Oct 31, 2024 . The former held 4.98 shares worth $49.47 million, making up 4.27% of all outstanding shares. On the other hand, Vanguard Total Stock Market Index Fund held roughly 3.48 shares worth around $34.62 million, which represents about 2.99% of the total shares outstanding.
